Awarded

Eribulina 0,44 mg/ml solución inyectable.

Name: Eribulina 0,44 mg/ml solución inyectable.
Creator: SERVICIO NAVARRO DE SALUD-OSASUNBIDEA
Published: 2026-03-10
License: https://ted.europa.eu/en/simap/legal-notice

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: SERVICIO NAVARRO DE SALUD-OSASUNBIDEA
Winners: EVER PHARMA TERAPEUTICS SPAIN, S.L.
Contract value: €25,688
Bids received: 3
Published: 10 Mar 2026
Awarded: 30 Jan 2026
Contract start: 30 Jan 2026
Contract end: 31 Jan 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Navarra
Source: Original notice on TED (168383-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
LOTE ÚNICO: Material fungible para mapeo y ablación cardiaca de doble energía	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	MEDTRONIC IBERICA SA	€426,934	24 Sept 2026
Ustekinumab 130 mg vial	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	BIOCON BIOLOGICS SPAIN, S.L.	€268,260	24 Sept 2026
Ustekinumab 45 mg jeringa/pluma y Ustekinumab 90 mg jeringa/pluma	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	BIOCON BIOLOGICS SPAIN, S.L.	€3,376,200	24 Sept 2026
TECVAYLI 90 MG/ML VIAL	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	JANSSEN CILAG, S.A.	—	17 Sept 2026
TALVEY (40 MG/ML) 40 MG VIAL	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	JANSSEN CILAG, S.A.	—	17 Sept 2026
SIMPONI 100 MG 1 PLUMA PRECARGADA	SERVICIO NAVARRO DE SALUD-OSASUNBIDEA	JANSSEN CILAG, S.A.	—	17 Sept 2026